respons
cellular
stress
program
signal
cascad
get
activ
known
unfold
protein
respons
upr
mediat
three
highli
specif
signal
protein
molecul
name
activ
transcript
factor
doublestrand
rnaactiv
protein
kinas
pkr
like
er
kinas
perk
inositol
requir
enzym
upr
regul
master
regul
protein
glucoseregul
protein
bind
immunoglobulin
protein
normal
condit
er
lumin
domain
transmembran
molecul
includ
perk
bound
chaperon
protein
maintain
inact
state
stress
condit
figur
misfold
unfold
protein
accumul
er
lumen
dissoci
transmembran
sensor
activ
upr
signal
pathway
downstream
target
gene
includ
chop
er
degradationenhanc
alphamannosidaselik
protein
growth
arrest
dna
damageinduc
gene
gadd
protein
kinas
inhibitor
kda
pdi
pathway
use
differ
mechan
perk
inhibit
translat
regul
proteolysi
act
degrad
er
bound
mrna
upon
activ
er
stress
pkrlike
er
kinas
perk
oligomer
autophosphoryl
free
lumin
domain
cytosol
domain
phosphoryl
subunit
translat
initi
factor
subsequ
inhibit
process
translat
thu
perk
help
reduc
burden
unfold
protein
howev
limit
translat
transcript
factor
induc
associ
two
target
gene
cebp
homolog
protein
chop
growth
arrest
dna
damageinduc
protein
chop
transcript
factor
control
gene
associ
apoptot
pathway
thu
phosphoryl
select
either
protect
apoptot
role
perk
epitom
effect
alter
relat
phosphatas
perk
induc
regulatori
subunit
protein
phosphatas
dephosphoryl
thu
revers
effect
perk
delet
inhibit
complex
format
may
protect
cell
figur
play
dual
role
transmembran
kinas
endoribonucleas
particip
mrna
splice
transmit
upr
signal
undergo
conform
chang
oligomer
er
membran
upon
activ
cleav
mrna
encod
xbox
bind
protein
two
specif
posit
excis
intron
final
give
rise
splice
mrna
translat
activ
form
figur
transcript
factor
target
gene
encod
er
chaperon
oxidoreductas
erad
pathway
compon
play
special
role
regul
lipid
biosynthet
enzym
erad
compon
well
element
involv
activ
secretori
pathway
figur
mammal
two
paralogu
ubiquit
express
requir
mrna
splice
express
restrict
intestin
epithelium
elimin
mice
lead
increas
sign
er
stress
increas
jnk
cjun
ntermin
kinas
signal
mice
highli
suscept
experiment
coliti
induc
dextran
sodium
sulfat
membranebound
transcript
factor
local
er
serv
sensor
er
stress
transcript
activ
upr
target
gene
upon
activ
unfold
misfold
protein
get
pinch
er
deliv
misfold
protein
golgi
apparatu
two
proteas
proteas
proteas
cleav
releas
ntermin
n
travel
nucleu
activ
upr
target
gene
among
target
major
erresid
protein
involv
protein
fold
disulfid
isomeras
chaperon
particip
refold
reliev
er
stress
promot
contain
three
er
stress
respons
element
ers
locat
upstream
tata
element
member
leucin
zipper
protein
famili
constitut
induc
promot
glucoseregul
protein
gene
activ
ers
also
known
induc
express
increas
sum
three
branch
upr
oppos
signal
rel
induct
may
shift
balanc
cytoprotect
apoptosi
complex
regul
increas
compon
upr
includ
perk
transcript
control
upr
tumor
microenviron
cellular
surround
tumor
includ
stromal
nonstrom
compon
stromal
cell
secret
cytokin
growth
factor
interact
tumor
cell
reciproc
manner
tumor
cell
affect
stromal
cell
phenotyp
modifi
microenviron
stromal
cell
support
tumor
cell
growth
promot
invas
metastasi
stromal
compon
tumor
microenviron
includ
endotheli
cell
immun
cell
inflammatori
cell
lymphocyt
cancer
associ
fibroblast
caf
extracellular
matrix
ecm
signal
molecul
tabl
activ
caf
tumor
microenviron
help
tumor
cell
prolifer
suppli
nutrit
also
secret
variou
growth
factor
hepatocyt
growth
factor
hgf
fibroblast
growth
factor
fgf
cytokin
caf
releas
larg
number
mesenchym
transduc
solubl
factor
remodel
ecm
endotheli
cell
line
tumor
blood
vessel
produc
proangiogen
factor
also
promot
migrat
metastasi
evad
anoiki
immun
cell
tumor
environ
may
either
activ
helper
cytotox
lymphocyt
mhc
mhc
ii
depend
manner
promot
tumor
growth
presenc
infiltr
leukocyt
state
previous
section
upr
affect
process
angiogenesi
inflamm
host
immun
respons
also
mediat
signal
tumor
nontumor
cell
cancer
cell
commun
messag
tumor
vicin
paracrin
effect
myeloid
cell
use
small
molecul
ion
protein
nucleic
acid
myeloid
infiltr
cell
becom
immunolog
toler
start
secret
mani
signal
molecul
growth
factor
cytokin
exosom
upr
enrich
tumor
fit
transmit
cancer
cell
cell
tumor
microenviron
transmiss
er
stress
ter
multipl
effect
recipi
cell
vitro
vivo
ter
upregul
tumorigen
inflammatori
cytokin
inflammatori
metabolit
decreas
cell
respons
ter
control
immun
cell
develop
function
surviv
patholog
physiolog
condit
tumor
microenviron
compris
hyperact
prooncogen
gene
mutant
tumor
suppressor
gene
respons
highli
prolif
metabol
demand
cellular
environ
due
metabol
demand
stress
environ
tumor
cell
thrive
condit
hypoxia
glucos
depriv
lactic
acidosi
oxid
stress
alter
nitrogen
speci
lipid
peroxid
decreas
amino
acid
suppli
premalign
cell
ad
advantag
gene
mutat
curb
upr
induc
apoptosi
senesc
promot
surviv
growth
chang
due
intrins
extrins
factor
microenviron
contribut
upr
activ
induc
er
stressor
unlik
normal
cell
cancer
cell
demonstr
constitut
activ
upr
system
stress
condit
mutant
lose
regul
decay
mrna
ridd
function
show
increas
cell
surviv
tumor
microenviron
poor
microcircul
caus
hypoxia
cell
hypoxia
lead
upr
activ
eventu
initi
anoth
cycl
cell
prolifer
subsequ
hypoxia
tumor
cell
although
hypoxia
ideal
gener
protein
translat
case
malign
hypoxia
induc
upregul
hypoxiainduc
factor
alpha
stimul
angiogenesi
activ
metastat
gene
hypoxia
trigger
perk
signal
mammalian
cell
line
upr
activ
mediat
downstream
effector
phosphoryl
activ
develop
hypoxia
toler
activ
hypoxicmodul
molecular
respons
depend
cellular
oxygen
level
durat
hypoxia
upr
mediat
induct
endoplasm
reticulum
oxidoreductin
lead
gener
reactiv
oxygen
speci
ro
mitochondria
er
hypoxia
ro
tumor
microenviron
promot
genet
epigenet
alter
favor
tumor
growth
progress
ro
target
er
resid
protein
er
base
calcium
channel
lead
er
stress
signal
increas
cytosol
calcium
calcium
ingress
mitochondria
er
stimul
ro
product
process
activ
perk
mediat
induct
promot
cancer
cell
prolifer
proinflammatori
cytokin
like
tumor
necrosi
factor
present
tumor
microenviron
add
er
stress
induc
upr
activ
three
branch
upr
pathway
activ
nfkb
differ
mechan
signal
translat
arrest
increas
nfkbikb
ratio
lead
nfkb
nuclear
transloc
activ
nfkb
akt
phosphoryl
receptorassoci
factor
complex
bind
nfkb
lead
ikb
phosphoryl
degrad
nuclear
transloc
nfkb
complex
initi
proapoptot
signal
activ
apoptosi
signal
regul
kinas
subsequ
transmit
death
signal
cjun
ntermin
kinas
jnk
jnk
phosphoryl
abrog
antiapoptot
activ
variou
inflammatori
mediat
eicosanoid
includ
prostaglandin
leukotrien
also
associ
er
stress
upr
vivo
studi
carri
murin
model
show
insulinsensit
effect
sirna
zileuton
due
downregul
ampk
activ
identifi
critic
player
er
stress
pathway
reactiv
oxygen
speci
ro
gener
inflamm
glucos
depriv
colorect
cancer
cell
increas
reduc
dehydrogenas
express
thu
upregul
extracellular
inflammatori
prostaglandin
promot
cancer
cell
surviv
studi
emphas
role
inflammatori
mediat
mediat
cell
surviv
adapt
tumor
microenviron
lead
novel
therapeut
strategi
anoth
eicosanoid
leukotrien
also
report
major
er
stress
mediat
also
observ
chemotherapi
trigger
oxid
stress
dna
damag
dsdna
break
tumor
cell
grow
glucos
defici
environ
caus
accumul
misfold
protein
within
er
affect
calcium
concentr
activ
perk
tumor
cell
switch
high
rate
aerob
glycolysi
produc
lactic
acid
activ
upr
compon
also
upregul
glucos
defici
tumor
microenviron
amino
acid
depriv
induc
phosphoryl
variou
growth
factor
like
epiderm
growth
factor
egf
transform
growth
releas
within
tumor
microenviron
activ
upr
wang
colleagu
demonstr
nutrient
defici
activ
upr
depend
manner
stimul
inflammatori
cytokin
il
fibroblast
growth
vascular
endotheli
growth
factor
vegf
signal
studi
suggest
upr
activ
tumor
cell
mark
intrins
extrins
factor
high
metabol
demand
tumor
microenviron
activ
upr
subsequ
augment
oncogen
mutat
tumor
suppressor
gene
increas
protein
synthesi
transloc
er
addit
cancer
cell
secretori
natur
prone
upr
activ
viral
infect
host
cell
depend
competit
viru
infect
host
respons
host
cell
conquer
get
acut
chronic
infect
step
viral
life
cycl
begin
viral
entri
replic
host
cell
releas
matur
virion
deleteri
host
express
viral
protein
imbal
calcium
concentr
viroporin
consequ
deplet
er
membran
due
releas
virion
caus
er
stress
host
cell
gener
load
unfold
misfold
protein
host
cell
gener
upr
promot
erad
pathway
viral
infect
virus
rnadna
viru
may
manipul
host
upr
way
maintain
environ
favor
infect
persist
diseas
cell
tabl
among
chronic
virus
famili
herpesvirus
util
host
upr
maintain
latenc
host
herpesviru
mimic
mani
host
molecul
util
upr
set
activ
lytic
infect
break
dormanc
latent
phase
therebi
prove
long
time
interact
viru
host
upr
case
gammaherpesvirus
human
herpesviru
kaposi
sarcoma
associ
herpesviru
kshv
studi
shown
primari
effus
lymphoma
pel
cell
immunophenotyp
similar
preplasma
cell
unsplic
mrna
er
stress
mrna
process
bind
kshv
promot
upregul
kshv
gene
express
induc
kshv
lytic
replic
eleg
studi
paul
lieberman
group
report
er
stress
due
differ
stimuli
trigger
cleavag
lytic
switch
pel
cell
also
found
er
stress
induc
dtt
protein
synthesi
inhibitor
effect
induc
cleavag
lytic
reactiv
other
exampl
subab
cytotoxin
tunicamycin
induc
partial
cleavag
slower
kinet
lower
amplitud
kshv
lytic
reactiv
slower
kinet
compound
may
associ
distinct
er
stress
induc
compar
broadli
act
chemic
inhibitor
may
modul
addit
pathway
activ
broader
rang
caspas
result
complet
cleavag
pel
cell
sensit
er
stressinduc
agent
like
chloroquin
link
defect
perk
particular
sensit
pel
cell
may
control
kshv
latenc
epigenet
similar
vitro
clinic
studi
shown
induct
er
stress
shut
viral
replic
lytic
gene
express
thu
studi
support
therapeut
potenti
glucosemannos
analog
gammaherpesviru
also
suggest
possibl
usag
approach
virusdriven
cancer
downregul
mrna
level
numer
viral
gene
requir
replic
includ
regul
transcript
activ
rta
therebi
impair
rta
transactiv
loop
subsequ
lead
inhibit
kshv
lytic
gene
transcript
cascad
studi
demonstr
util
arachidon
acid
aa
pathway
enzym
leukotrien
hydrolas
metabolit
prostaglandin
leukotrien
life
cycl
especi
mainten
latenc
effect
inhibit
pathway
could
potenti
use
treatment
control
kspel
unpublish
result
lab
demonstr
kshv
infect
induc
serv
link
kshv
life
cycl
adapt
host
cell
er
stress
use
bestatin
wellknown
inhibitor
silenc
induc
prolifer
arrest
kshv
pel
cell
compar
noninfect
bjab
burkitt
lymphoma
cell
inhibit
induc
er
stress
protein
calnexin
bip
chop
stimul
phosphoryl
perk
might
caus
translat
arrest
apoptosi
pel
also
demonstr
kshv
infect
downregul
antiinflammatori
proresolv
metabolit
lipoxin
success
viral
life
cycl
pathogenesi
proven
varicellazost
viru
vzv
possess
smallest
genom
human
herpesvirus
lack
gene
use
herpesvirus
manipul
upr
later
john
carpent
charl
grose
establish
vzv
differenti
induc
upregul
upr
deal
viral
glycoprotein
synthesi
vzv
upregul
camp
respons
element
bind
protein
h
atyp
upr
molecul
clearli
pave
way
futur
studi
disclos
relationship
vzv
upr
mani
virus
evolv
mechan
antagon
upr
induc
phosphoryl
translat
control
among
virus
herp
simplex
viru
hsvi
encod
protein
homolog
cellular
protein
dephosphoryl
protein
translat
proceed
likewis
african
swine
fever
viru
encod
show
homolog
hsv
protein
also
associ
enzym
dephosphoryl
paradox
protein
expect
induc
er
stress
low
level
act
inhibitor
er
stress
instead
exampl
hcv
viral
envelop
glycoprotein
gb
work
specif
inhibitor
perk
er
stress
upr
aid
viral
replic
human
cytomegaloviru
protein
herpesviru
activ
upr
increas
degrad
class
major
histocompat
complex
protein
result
escap
host
immun
respons
mani
reovirus
compet
host
mrna
molecul
increas
express
induc
phosphoryl
benefici
viral
replic
promot
hepat
b
viru
hbv
upregul
er
stress
thu
conclud
virus
evolv
mechan
flee
neg
effect
er
stress
concurr
exploit
prefer
upr
induc
factor
advantag
case
sever
acut
respiratori
syndrom
coronaviru
sarscov
accessori
viral
protein
bind
domain
thu
induc
proteolysi
cleav
dna
bind
transcript
activ
domain
move
er
nucleu
find
suggest
virus
may
exploit
protein
directli
modul
upr
respons
virus
also
exploit
erad
pathway
degrad
immun
molecul
viral
envelop
glycoprotein
escap
immun
respons
host
polyomavirus
use
erad
life
cycl
uncoat
capsid
present
nuclear
local
signal
capsid
protein
initi
viral
dna
replic
virion
matur
virus
hinder
erad
tune
use
eradassoci
machineri
form
isol
lipid
vesicl
replic
escap
immun
detect
upr
host
much
homeostat
cellular
respons
viru
infect
upr
close
associ
inflammatori
pathway
innat
immun
induc
host
pattern
recognit
receptor
prr
respons
profession
viru
killer
get
activ
releas
interferon
one
proxim
upr
sensor
inositolrequir
enzym
activ
decay
ridd
evolutionarili
relat
viru
killer
rnase
l
sinc
virus
natur
infect
transfer
dna
host
cell
viral
vector
increasingli
use
gene
deliveri
vehicl
gene
therapi
vector
base
retrovirus
integr
viral
genom
chromosom
dna
host
cell
episom
vector
like
adenoviru
deliv
genom
nucleu
target
cell
continu
separ
extrachromosom
element
vaccinia
viral
vector
also
use
cancer
gene
therapi
profici
infect
gene
express
complex
tumor
also
safeti
profil
vaccinia
viru
alreadi
determin
due
use
vaccin
small
pox
human
virus
herpesvirida
famili
vzv
ebv
also
use
cancer
gene
therapi
ebv
owe
specif
b
cell
util
deliv
granulocytemacrophag
colonystimul
factor
gmcsf
therapi
patient
bcell
chronic
lymphocyt
leukemia
bcll
sinc
ebv
virus
infect
cell
modif
valid
essenti
make
safe
enough
use
gene
therapi
becom
significantli
import
studi
understand
viru
host
interact
viral
vector
use
gene
therapi
discuss
stress
stimuli
tumor
microenviron
activ
upr
influenc
cellular
process
metastat
growth
apoptosi
inflamm
host
immun
respons
two
strateg
plan
target
upr
signal
one
effect
kill
cancer
cell
hinder
uprmedi
adapt
respons
may
help
tumor
cell
prolifer
harsh
tumor
microenviron
condit
resist
treatment
upr
effector
upregul
vegfa
proangiogen
factor
cancer
cell
includ
breast
cancer
master
regul
er
stress
respons
help
premalign
cell
adapt
upr
induc
apoptosi
therapeut
strategi
aim
reduc
target
upr
sensor
effect
cancer
increas
varieti
cancer
type
includ
breast
lung
colon
prostat
skin
melanoma
mani
malign
studi
similar
studi
past
report
high
level
associ
rapid
prolifer
malign
tumor
breast
cancer
cell
associ
estrogen
receptor
increas
abund
signifi
cell
prolifer
improv
resist
er
stress
sirnamedi
knockdown
estrogen
receptor
strateg
use
prevent
tumor
progress
case
similarli
chemotherapeut
agent
use
reduc
glioblastoma
cell
line
solid
tumor
therapi
increas
express
chop
caspas
lead
inhibit
tumor
format
final
induc
cellular
apoptosi
posit
regul
mitogen
activ
protein
kinas
mapk
pathway
thu
inhibit
mapk
pathway
boost
mediat
er
stress
induc
apoptosi
melanoma
cell
moreov
antitumor
agent
decreas
protein
level
directli
bind
facilit
degrad
base
characterist
consid
biomark
cancer
progress
sinc
inhibit
play
cytoprotect
role
therefor
util
develop
treatment
strategi
multidrug
resist
cancer
likewis
upr
signal
transduc
proteasom
inhibitor
bortezomib
involv
activ
upr
also
use
check
cancer
progress
repres
regul
plasma
cell
differenti
overexpress
critic
multipl
myeloma
induct
inhibit
splice
shown
reduc
multipl
myeloma
cell
growth
splice
induc
prompt
cellular
prolifer
increas
express
cyclin
thu
inhibit
may
expos
multipl
myeloma
cell
er
stress
reduc
surviv
chevet
et
al
group
scientist
shown
direct
therapeut
target
rnase
activ
reduc
progress
variou
form
cancer
similar
approach
pursu
variou
model
experiment
glioblastoma
studi
human
cancer
tissu
sampl
cancer
genom
atla
research
network
parson
et
al
reveal
presenc
three
somat
mutat
gene
gbm
chevet
et
al
also
show
antagonist
role
ridd
tumor
growth
ridd
mrna
depict
antitumor
featur
remodel
tumor
stroma
recent
studi
shown
inhibitor
restor
sensit
tamoxifen
tamoxifen
resist
cell
line
synergist
effect
drug
significantli
delay
breast
cancer
progress
clinic
trial
demonstr
express
level
highli
correl
cell
surviv
er
breast
cancer
patient
loss
link
spontan
intestin
inflamm
inflammatori
bowel
diseas
human
modul
signal
like
toyocamycin
therapeut
use
case
multipl
myeloma
inhibitor
shown
kill
cancer
cell
sensit
common
chemo
radiotherapi
inhibitor
mrna
splice
work
effici
affect
phosphoryl
oligomer
neg
regul
gene
involv
cellular
senesc
mediat
cell
surviv
upregul
compon
autophagosom
membran
also
respons
upregul
thu
express
liver
cancer
hypox
condit
pathway
increas
cell
growth
surviv
cancer
cell
sinc
perk
activ
mani
angiogen
gene
inhibit
found
success
reduc
tumor
growth
vitro
vivo
recent
lab
ongo
studi
found
salubrin
effici
curb
dephosphoryl
thu
use
potenti
therapi
inflammatori
breast
cancer
result
indic
new
therapeut
antitumor
agent
inhibit
er
chaperon
level
upr
adapt
prosurviv
pathway
util
potenti
cancer
therapi
improv
outcom
recent
two
anticanc
drug
act
atp
competit
inhibitor
target
signal
base
either
phosphoryl
inhibit
prolong
phosphoryl
introduc
inhibit
phosphoryl
perk
caus
increas
er
protein
load
reduc
adapt
er
stress
lead
cell
death
report
reduc
tumor
growth
mous
xenograft
model
recent
integr
stress
respons
inhibitor
isrib
identifi
new
perk
signal
inhibitor
rather
inhibit
perk
phosphoryl
block
downstream
process
revers
effect
phosphoryl
isrib
treatment
affect
surviv
cell
er
stress
one
major
undesir
consequ
cancer
therapi
mani
anticanc
drug
activ
upr
lead
drug
resist
patient
thu
recent
combin
therapeut
approach
prove
effici
upr
activ
exampl
usag
pdi
inhibitor
resensit
tumor
cell
imatinib
leukemia
cell
likewis
doxorubicin
salubrin
along
bortezomib
effect
diffus
larg
b
cell
lymphoma
hepatoma
respect
moreov
case
multipl
myeloma
toyocamycin
effect
bortezomib
resist
three
branch
upr
help
tumor
cell
surviv
harsh
tumor
microenviron
also
signal
surround
nontumor
cell
facilit
cancer
progress
contradictori
complex
role
transduc
regul
antitumor
host
respons
make
difficult
put
practic
usag
target
therapi
cancer
upr
transduc
regul
intrins
timer
eg
prolong
er
stress
guid
decay
ridd
lead
apoptosi
perk
activ
deactiv
regul
similar
manner
three
branch
upr
may
transcript
factor
activ
singl
target
chop
play
vital
role
decid
fate
cell
silenc
singl
compon
upr
time
ration
therapeut
approach
target
may
requir
coordin
two
branch
upr
current
experiment
model
use
monitor
chang
tumor
cell
stress
exampl
seen
hypoxia
initi
phase
phosphoryl
lead
protein
attenu
follow
transient
period
protein
synthesi
perman
reduct
process
translat
find
suggest
effect
futur
drug
must
timedepend
said
regul
upr
system
affect
cell
apoptosi
differ
way
either
exhibit
chaperon
activ
prevent
upr
sensor
activ
preserv
er
calcium
homeostasi
elev
level
usual
associ
higher
patholog
grade
recurr
poor
patient
surviv
cancer
breast
liver
prostat
colon
assist
tumor
progress
spread
drug
resist
moreov
dormant
tumor
cell
quiescent
tumor
cell
reli
escap
chemotherapi
sever
natur
occur
compound
anticanc
activ
genistein
activ
compon
soy
epigallocatechin
gallat
compon
green
tea
salicycl
acid
plant
inhibit
either
express
activ
cancer
versipelostatin
repressor
express
use
target
upr
promot
apoptosi
els
usag
proteasom
inhibitor
may
overload
upr
overal
ideal
approach
would
compos
target
without
toxic
ideal
upr
inhibitor
must
specif
target
tumor
tissu
need
monitor
potenti
toxic
inhibitor
bcell
pancreat
futur
drug
discoveri
effort
tissu
specif
upr
pattern
might
help
differenti
target
tissu
prevent
inevit
tumor
progress
chemotherapi
activ
upr
compon
particularli
perk
arrest
cell
cycl
temporarili
tumor
regrow
effect
therapi
subsid
cell
adapt
stress
addit
inhibit
one
branch
might
result
alter
signal
branch
discuss
previous
icd
induct
upr
play
signific
role
develop
novel
anticanc
strategi
studi
shown
checkpoint
blockad
immunotherapi
consid
patient
tumor
infiltr
tumorinfiltr
lymphocyt
til
prior
treatment
case
chemotherapi
induc
icd
consid
along
immunogen
chemotherapi
may
induc
upr
respons
conclus
capabl
upr
manag
cell
fate
seem
potenti
cancer
therapeut
target
howev
contradictori
effect
upr
signal
pathway
well
confound
factor
must
address
come
treatment
plan
involv
er
stress
regul
